Geron to Participate at Upcoming Investor Conferences in March 2025
Geron (Nasdaq: GERN), a commercial-stage biopharmaceutical company, has announced its management team's upcoming participation in three major healthcare investor conferences in March 2025:
• TD Cowen 45th Annual Health Care Conference - March 3rd at 3:10pm ET in Boston, MA
• Leerink Global Healthcare Conference - March 10th at 3:00pm ET in Miami, FL
• Barclays 27th Annual Global Healthcare Conference - March 11th at 10:30am ET in Miami, FL
The company will participate in fireside chats at each event. Live webcasts will be accessible through the Investors & Media section of Geron's website under Events, with replays available for 30 days after each presentation.
Geron (Nasdaq: GERN), un'azienda biofarmaceutica in fase commerciale, ha annunciato la partecipazione del suo team di gestione a tre importanti conferenze per investitori nel settore sanitario a marzo 2025:
• TD Cowen 45a Conferenza Annuale sulla Salute - 3 marzo alle 15:10 ET a Boston, MA
• Leerink Conferenza Globale sulla Salute - 10 marzo alle 15:00 ET a Miami, FL
• Barclays 27a Conferenza Globale Annuale sulla Salute - 11 marzo alle 10:30 ET a Miami, FL
L'azienda parteciperà a discussioni informali in ciascun evento. Le trasmissioni in diretta saranno accessibili attraverso la sezione Investitori & Media del sito web di Geron sotto Eventi, con riproduzioni disponibili per 30 giorni dopo ogni presentazione.
Geron (Nasdaq: GERN), una compañía biofarmacéutica en etapa comercial, ha anunciado la próxima participación de su equipo de gestión en tres importantes conferencias de inversores en el sector salud en marzo de 2025:
• 45ª Conferencia Anual de Salud de TD Cowen - 3 de marzo a las 3:10 p.m. ET en Boston, MA
• Conferencia Global de Salud de Leerink - 10 de marzo a las 3:00 p.m. ET en Miami, FL
• 27ª Conferencia Global Anual de Salud de Barclays - 11 de marzo a las 10:30 a.m. ET en Miami, FL
La compañía participará en charlas informales en cada evento. Las transmisiones en vivo estarán disponibles a través de la sección de Inversores y Medios en el sitio web de Geron bajo Eventos, con repeticiones disponibles durante 30 días después de cada presentación.
Geron (Nasdaq: GERN), 상업 단계의 바이오 제약 회사는 2025년 3월에 있을 세 가지 주요 의료 투자자 회의에 경영진 팀이 참석할 것이라고 발표했습니다:
• TD Cowen 제45회 연례 의료 회의 - 3월 3일 오후 3시 10분 ET, 보스턴, MA
• Leerink 글로벌 헬스케어 회의 - 3월 10일 오후 3시 ET, 마이애미, FL
• Barclays 제27회 연례 글로벌 헬스케어 회의 - 3월 11일 오전 10시 30분 ET, 마이애미, FL
회사는 각 이벤트에서 대화형 세션에 참여할 예정입니다. 실시간 웹 방송은 Geron의 웹사이트의 투자자 및 미디어 섹션의 이벤트 아래에서 접근할 수 있으며, 각 발표 후 30일 동안 다시 볼 수 있습니다.
Geron (Nasdaq: GERN), une entreprise biopharmaceutique en phase commerciale, a annoncé la prochaine participation de son équipe de direction à trois grandes conférences d'investisseurs en santé en mars 2025 :
• 45ème Conférence Annuelle de Soins de Santé de TD Cowen - 3 mars à 15h10 ET à Boston, MA
• Conférence Mondiale de Soins de Santé de Leerink - 10 mars à 15h00 ET à Miami, FL
• 27ème Conférence Annuelle Mondiale de Soins de Santé de Barclays - 11 mars à 10h30 ET à Miami, FL
L'entreprise participera à des discussions informelles lors de chaque événement. Des diffusions en direct seront accessibles via la section Investisseurs & Médias du site Web de Geron sous Événements, avec des rediffusions disponibles pendant 30 jours après chaque présentation.
Geron (Nasdaq: GERN), ein biopharmazeutisches Unternehmen in der kommerziellen Phase, hat die bevorstehende Teilnahme seines Managementteams an drei bedeutenden Investorenkonferenzen im Gesundheitswesen im März 2025 angekündigt:
• 45. TD Cowen Jahrestagung zur Gesundheitsversorgung - 3. März um 15:10 Uhr ET in Boston, MA
• Leerink Globale Gesundheitskonferenz - 10. März um 15:00 Uhr ET in Miami, FL
• 27. Barclays Globale Gesundheitskonferenz - 11. März um 10:30 Uhr ET in Miami, FL
Das Unternehmen wird an informellen Gesprächen bei jedem Event teilnehmen. Live-Übertragungen werden über den Bereich Investoren & Medien auf der Website von Geron unter Veranstaltungen zugänglich sein, mit Wiederholungen, die 30 Tage nach jeder Präsentation verfügbar sind.
- None.
- None.
-
TD Cowen 45th Annual Health Care Conference
Monday, March 3rd at 3:10pm ET (Boston, MA )
-
Leerink Global Healthcare Conference
Monday, March 10th 3:00pm ET (Miami, FL )
-
Barclays 27th Annual Global Healthcare Conference
Tuesday, March 11th 10:30am ET (Miami, FL )
A live webcast of each fireside chat will be available through the Investors & Media section of the Geron’s website under Events. A replay of the webcast will be archived and available on Geron’s website for 30 days.
About Geron
Geron is a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer. Our first-in-class telomerase inhibitor RYTELO® (imetelstat) is approved in
View source version on businesswire.com: https://www.businesswire.com/news/home/20250221535654/en/
Aron Feingold
Vice President, Investor Relations and Corporate Communications
Kristen Kelleher
Associate Director, Investor Relations and Corporate Communications
investor@geron.com
media@geron.com
Source: Geron Corporation